|
Volumn 21, Issue 7, 2013, Pages 1621-1627
|
Novel leucine ureido derivatives as inhibitors of aminopeptidase N (APN)
|
Author keywords
Aminopeptidase N; Inhibitors; Leucine ureido derivatives; Synthesis
|
Indexed keywords
2 [3 (2 BROMOBENZYL)UREIDO] 4 METHYL PENTANOIC ACID HYDROXYAMIDE;
2 [3 (2 BROMOPHENYL)UREIDO] 4 METHYL PENTANOIC ACID HYDROXYAMIDE;
2 [3 (2 CHLOROBENZYL)UREIDO] 4 METHYL PENTANOIC ACID HYDROXYAMIDE;
2 [3 (2 CHLOROPHENYL)UREIDO] 4 METHYL PENTANOIC ACID HYDROXYAMIDE;
2 [3 (2 FLUOROBENZYL)UREIDO] 4 METHYL PENTANOIC ACID HYDROXYAMIDE;
2 [3 (2 FLUOROPHENYL)UREIDO] 4 METHYL PENTANOIC ACID HYDROXYAMIDE;
2 [3 (2 HYDROXYPHENYL)UREIDO] 4 METHYL PENTANOIC ACID HYDROXYAMIDE;
2 [3 (2 METHOXYPHENYL)UREIDO] 4 METHYL PENTANOIC ACID HYDROXYAMIDE;
2 [3 (3 BROMOPHENYL)UREIDO] 4 METHYL PENTANOIC ACID HYDROXYAMIDE;
2 [3 (3 CHLOROBENZYL)UREIDO] 4 METHYL PENTANOIC ACID HYDROXYAMIDE;
2 [3 (3 CHLOROPHENYL)UREIDO] 4 METHYL PENTANOIC ACID HYDROXYAMIDE;
2 [3 (3 FLUOROPHENYL)UREIDO] 4 METHYL PENTANOIC ACID HYDROXYAMIDE;
2 [3 (3 HYDROXYPHENYL)UREIDO] 4 METHYL PENTANOIC ACID HYDROXYAMIDE;
2 [3 (3 METHOXYPHENYL)UREIDO] 4 METHYL PENTANOIC ACID HYDROXYAMIDE;
4 METHYL 2 (3 M TOLYL UREIDO)PENTANOIC ACID PENTANOIC ACID HYDROXYAMIDE;
4 METHYL 2 (3 O TOLYL UREIDO)PENTANOIC ACID PENTANOIC ACID HYDROXYAMIDE;
4 METHYL 2 [3 (2 METHYLBENZYL)UREIDO]PENTANOIC ACID HYDROXYAMIDE;
4 METHYL 2 [3 (2 TRIFLUOROMETHYL PHENYL)UREIDO]PENTANOIC ACID HYDROXYAMIDE;
4 METHYL 2 [3 (3 METHYLBENZYL)UREIDO]PENTANOIC ACID HYDROXYAMIDE;
4 METHYL 2 [3 (3 TRIFLUOROMETHYL PHENYL)UREIDO]PENTANOIC ACID HYDROXYAMIDE;
BESTATIN;
HISTONE DEACETYLASE 1;
HISTONE DEACETYLASE 3;
HISTONE DEACETYLASE 5;
HISTONE DEACETYLASE 8;
LEUCINE UREIDO DERIVATIVE;
MICROSOMAL AMINOPEPTIDASE;
PEPTIDE HYDROLASE INHIBITOR;
UNCLASSIFIED DRUG;
VORINOSTAT;
ARTICLE;
CELL ASSAY;
CHEMICAL MODIFICATION;
CONCENTRATION RESPONSE;
CONTROLLED STUDY;
DRUG DESIGN;
DRUG POTENCY;
DRUG SYNTHESIS;
ENZYME INHIBITION;
HUMAN;
HUMAN CELL;
IC 50;
STRUCTURE ACTIVITY RELATION;
ANIMALS;
ANTIGENS, CD13;
ANTINEOPLASTIC AGENTS;
CELL LINE, TUMOR;
DRUG DESIGN;
HUMANS;
INHIBITORY CONCENTRATION 50;
LEUCINE;
MOLECULAR DOCKING SIMULATION;
NEOPLASMS;
PROTEASE INHIBITORS;
SWINE;
|
EID: 84875218168
PISSN: 09680896
EISSN: 14643391
Source Type: Journal
DOI: 10.1016/j.bmc.2013.01.068 Document Type: Article |
Times cited : (15)
|
References (20)
|